BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
32 results:

  • 1. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
    Duan DK; Zhang GC; Sun BJ; Ma TX; Zhao M
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5039-5052. PubMed ID: 37318478
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
    Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
    J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
    Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tissue segmentation-based electron density mapping for MR-only radiotherapy treatment planning of brain using conventional T1-weighted MR images.
    Yu H; Oliver M; Leszczynski K; Lee Y; Karam I; Sahgal A
    J Appl Clin Med Phys; 2019 Aug; 20(8):11-20. PubMed ID: 31257709
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. UTE-mDixon-based thorax synthetic CT generation.
    Su KH; Friel HT; Kuo JW; Al Helo R; Baydoun A; Stehning C; Crisan AN; Traughber MS; Devaraj A; Jordan DW; Qian P; Leisser A; Ellis RJ; Herrmann KA; Avril N; Traughber BJ; Muzic RF
    Med Phys; 2019 Aug; 46(8):3520-3531. PubMed ID: 31063248
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with ndrg1.
    Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning.
    Wiesinger F; Bylund M; Yang J; Kaushik S; Shanbhag D; Ahn S; Jonsson JH; Lundman JA; Hope T; Nyholm T; Larson P; Cozzini C
    Magn Reson Med; 2018 Oct; 80(4):1440-1451. PubMed ID: 29457287
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation Therapy.
    Johnstone E; Wyatt JJ; Henry AM; Short SC; Sebag-Montefiore D; Murray L; Kelly CG; McCallum HM; Speight R
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):199-217. PubMed ID: 29254773
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners.
    Koivula L; Kapanen M; Seppälä T; Collan J; Dowling JA; Greer PB; Gustafsson C; Gunnlaugsson A; Olsson LE; Wee L; Korhonen J
    Radiother Oncol; 2017 Dec; 125(3):411-419. PubMed ID: 29097012
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ndrg1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy.
    Wang H; Li W; Xu J; Zhang T; Zuo D; Zhou Z; Lin B; Wang G; Wang Z; Sun W; Sun M; Chang S; Cai Z; Hua Y
    Cell Death Dis; 2017 Sep; 8(9):e3048. PubMed ID: 28906492
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effects of long-term low oxygen tension in human chondrosarcoma cells.
    Piltti J; Bygdell J; Qu C; Lammi MJ
    J Cell Biochem; 2018 Feb; 119(2):2320-2332. PubMed ID: 28865129
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.
    Lee Y; Park S; Lee SH; Lee H
    BMC Cancer; 2017 May; 17(1):330. PubMed ID: 28506304
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning.
    Guerreiro F; Burgos N; Dunlop A; Wong K; Petkar I; Nutting C; Harrington K; Bhide S; Newbold K; Dearnaley D; deSouza NM; Morgan VA; McClelland J; Nill S; Cardoso MJ; Ourselin S; Oelfke U; Knopf AC
    Phys Med; 2017 Mar; 35():7-17. PubMed ID: 28242137
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ndr1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3.
    Ma C; Lin W; Liu Z; Tang W; Gautam R; Li H; Qian Y; Huang H; Wang X
    EMBO Rep; 2017 Apr; 18(4):586-602. PubMed ID: 28219902
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin.
    Dubon MJ; Yu J; Choi S; Park KS
    J Cell Physiol; 2018 Jan; 233(1):201-213. PubMed ID: 28213973
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
    Koivula L; Wee L; Korhonen J
    Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma.
    Slotkin EK; Patwardhan PP; Vasudeva SD; de Stanchina E; Tap WD; Schwartz GK
    Mol Cancer Ther; 2015 Feb; 14(2):395-406. PubMed ID: 25519700
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.
    Korhonen J; Kapanen M; Keyriläinen J; Seppälä T; Tenhunen M
    Med Phys; 2014 Jan; 41(1):011704. PubMed ID: 24387496
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Return to primary service among bone marrow transplant rehabilitation inpatients: an index for predicting outcomes.
    Fu JB; Lee J; Smith DW; Guo Y; Bruera E
    Arch Phys Med Rehabil; 2013 Feb; 94(2):356-61. PubMed ID: 23022262
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.